Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

The Journal of Integrative and Complementary Medicine, published by MARY ANN LIEBERT, INC, is at the forefront of exploring the interdisciplinary realms of complementary and alternative medicine. With its ISSN of 2768-3605 and E-ISSN 2768-3613, this prestigious journal has rapidly established itself as an essential resource for researchers, clinicians, and policymakers, evidenced by its Q1 ranking in Complementary and Alternative Medicine for 2023 and a Scopus rank of #31 out of 105 in this category. Spanning converged years from 2022 to 2024, the journal emphasizes rigorous research, innovative practices, and the integration of diverse healing modalities. As an open access journal, it provides readers with unparalleled access to high-quality studies, fostering collaboration and knowledge sharing in a field critical to holistic health approaches. The journal's commitment to advancing the understanding of integrative wellness is vital, particularly as healthcare continues to evolve and integrate various therapeutic practices.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Recent Patents on Anti-Cancer Drug Discovery, published by Bentham Science Publishers Ltd, is an esteemed peer-reviewed journal specializing in the innovative intersection of pharmaceutical science and oncology. With an ISSN of 1574-8928 and an E-ISSN of 2212-3970, this journal aims to provide a comprehensive platform for the dissemination of recent developments in anti-cancer drug discovery, addressing critical issues and breakthroughs that influence cancer research and treatment. The journal spans from 2006 to 2024 and is indexed in several prestigious databases, showcasing its relevance with a Q3 ranking in key categories such as Cancer Research and Drug Discovery as of 2023. Its status of being open access reflects a commitment to making valuable scientific findings widely available, promoting collaboration and advancement in the field. With a dedicated focus on advancing knowledge in cancer therapeutics, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to contribute to the fight against cancer.

The Journal of Evidence-Based Integrative Medicine is a prestigious publication dedicated to advancing the field of complementary and alternative medicine, published by SAGE Publications Inc. With an impressive Q1 ranking in the field and a Scopus rank of #21 out of 105, this journal positions itself at the forefront of research, achieving a notable 80th percentile performance. Since its transition to Open Access in 2018, it has provided a platform for researchers, professionals, and students to disseminate and access high-quality evidence-based studies that fuse traditional and modern health practices. The journal is essential for those aiming to explore integrative approaches and their applications in modern healthcare, making significant contributions to the dialogue surrounding holistic treatment methodologies. Published in the United Kingdom, it covers a wide array of topics related to integrative medicine and aims to facilitate collaboration and knowledge-sharing across disciplines.

Alternative Therapies in Health and Medicine is a distinguished peer-reviewed journal, published by InnoVision Professional Media, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has provided a platform for the dissemination of research focusing on holistic approaches to healthcare, innovative therapies, and integrative practices. With an ISSN of 1078-6791 and an E-ISSN of 1078-6791, it offers valuable insights crucial for researchers, healthcare professionals, and students alike. While the journal currently holds a Q3 ranking in both Complementary and Alternative Medicine and Miscellaneous Medicine categories as of 2023, it aims to foster an inclusive dialogue surrounding non-conventional medical practices and their integration into mainstream health paradigms. As the journal continues its journey through 2024, it remains steadfast in its objective to enrich academic discourse and promote evidence-based alternative therapies. Access to the journal is available through institutional subscriptions, enhancing its reach within the global academic community.

International Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.

Precision Medical Sciences is a pioneering open-access journal, launched in 2020 and published by the esteemed WILEY, dedicated to disseminating cutting-edge research and advancements in the field of precision medicine. With the ISSN 2642-2514, this journal serves as a critical platform for researchers, healthcare professionals, and students to explore innovative approaches that personalize medical treatment, optimize patient outcomes, and advance the understanding of patient variability in response to therapies. The adoption of open-access policies ensures that groundbreaking findings are readily available to the global scientific community, fostering collaboration and knowledge sharing among experts. Although currently lacking an H-index, the journal aspires to establish a robust reputation in the medical literature landscape, supporting the ongoing evolution of tailored healthcare solutions. Researchers are encouraged to contribute their findings to enhance the journal’s commitment to excellence in precision medical sciences.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.